QQ客服 官方微博 反馈留言

	Sitagliptin reduces insulin resistance and improves rat liver steatosis via the SIRT1/AMPK pathway
	Shen, Tian; Xu, Bilin; Lei, Tao; Chen, Lin; Zhang, Cuiping; Ni, Zhenhua
刊名	EXPERIMENTAL AND THERAPEUTIC MEDICINE
	2018
卷号	16期号:4
关键词	non-alcoholic fatty liver disease sitagliptin liver steatosis insulin resistance adenosine monophosphate-activated protein kinase pathway
ISSN号	1792-0981
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3635381
专题	上海中医药大学
推荐引用方式 GB/T 7714	Shen, Tian,Xu, Bilin,Lei, Tao,et al. Sitagliptin reduces insulin resistance and improves rat liver steatosis via the SIRT1/AMPK pathway[J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE,2018,16(4).
APA	Shen, Tian,Xu, Bilin,Lei, Tao,Chen, Lin,Zhang, Cuiping,&Ni, Zhenhua.(2018).Sitagliptin reduces insulin resistance and improves rat liver steatosis via the SIRT1/AMPK pathway.EXPERIMENTAL AND THERAPEUTIC MEDICINE,16(4).
MLA	Shen, Tian,et al."Sitagliptin reduces insulin resistance and improves rat liver steatosis via the SIRT1/AMPK pathway".EXPERIMENTAL AND THERAPEUTIC MEDICINE 16.4(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。